# BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease

> **NCT07138560** · PHASE4 · RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 22 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** CREXONT ER

## Key facts

- **NCT ID:** NCT07138560
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-24
- **Primary completion:** 2026-05-15
- **Final completion:** 2027-05-15
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07138560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07138560, "BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07138560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*